Global Orally Administered Vaccine Market Research Report 2024(Status and Outlook)
Report Overview:
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.
The Global Orally Administered Vaccine Market Size was estimated at USD 2692.07 million in 2023 and is projected to reach USD 3754.37 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.
This report provides a deep insight into the global Orally Administered Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orally Administered Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orally Administered Vaccine market in any manner.
Global Orally Administered Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orally Administered Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Orally administered vaccines are of interest, as they elicit both systemic and mucosal immunities, in which mucosal immunity would neutralize the mucosa invading pathogen before the onset of an infection.
The Global Orally Administered Vaccine Market Size was estimated at USD 2692.07 million in 2023 and is projected to reach USD 3754.37 million by 2029, exhibiting a CAGR of 5.70% during the forecast period.
This report provides a deep insight into the global Orally Administered Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orally Administered Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orally Administered Vaccine market in any manner.
Global Orally Administered Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Market Segmentation (by Type)
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Other
Market Segmentation (by Application)
Public
Private
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Orally Administered Vaccine Market
- Overview of the regional outlook of the Orally Administered Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orally Administered Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
1.2 Key Market Segments
1.2.1 Orally Administered Vaccine Segment by Type
1.2.2 Orally Administered Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ORALLY ADMINISTERED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ORALLY ADMINISTERED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Orally Administered Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orally Administered Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orally Administered Vaccine Sales Sites, Area Served, Product Type
3.6 Orally Administered Vaccine Market Competitive Situation and Trends
3.6.1 Orally Administered Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ORALLY ADMINISTERED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Orally Administered Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ORALLY ADMINISTERED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Orally Administered Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Orally Administered Vaccine Price by Type (2019-2024)
7 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orally Administered Vaccine Market Sales by Application (2019-2024)
7.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
8 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Orally Administered Vaccine Sales by Region
8.1.1 Global Orally Administered Vaccine Sales by Region
8.1.2 Global Orally Administered Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Orally Administered Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orally Administered Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orally Administered Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orally Administered Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orally Administered Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Orally Administered Vaccine Basic Information
9.1.2 Merck Orally Administered Vaccine Product Overview
9.1.3 Merck Orally Administered Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Orally Administered Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Orally Administered Vaccine Basic Information
9.2.2 GSK Orally Administered Vaccine Product Overview
9.2.3 GSK Orally Administered Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Orally Administered Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Orally Administered Vaccine Basic Information
9.3.2 Sanofi Orally Administered Vaccine Product Overview
9.3.3 Sanofi Orally Administered Vaccine Product Market Performance
9.3.4 Sanofi Orally Administered Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Orally Administered Vaccine Basic Information
9.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
9.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Orally Administered Vaccine Basic Information
9.5.2 Serum Institute Orally Administered Vaccine Product Overview
9.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Orally Administered Vaccine Basic Information
9.6.2 Valneva Orally Administered Vaccine Product Overview
9.6.3 Valneva Orally Administered Vaccine Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Orally Administered Vaccine Basic Information
9.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
9.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Orally Administered Vaccine Basic Information
9.8.2 Bibcol Orally Administered Vaccine Product Overview
9.8.3 Bibcol Orally Administered Vaccine Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Orally Administered Vaccine Basic Information
9.9.2 PaxVax Orally Administered Vaccine Product Overview
9.9.3 PaxVax Orally Administered Vaccine Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Orally Administered Vaccine Basic Information
9.10.2 Vabiotech Orally Administered Vaccine Product Overview
9.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Orally Administered Vaccine Basic Information
9.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
9.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Orally Administered Vaccine Basic Information
9.12.2 EuBiologics Orally Administered Vaccine Product Overview
9.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Orally Administered Vaccine Basic Information
9.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
9.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Orally Administered Vaccine Basic Information
9.14.2 Bio-Med Orally Administered Vaccine Product Overview
9.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
10 ORALLY ADMINISTERED VACCINE MARKET FORECAST BY REGION
10.1 Global Orally Administered Vaccine Market Size Forecast
10.2 Global Orally Administered Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Orally Administered Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Orally Administered Vaccine Market Size Forecast by Region
10.2.4 South America Orally Administered Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Orally Administered Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Orally Administered Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Orally Administered Vaccine by Type (2025-2030)
11.1.2 Global Orally Administered Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Orally Administered Vaccine by Type (2025-2030)
11.2 Global Orally Administered Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Orally Administered Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Orally Administered Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
1.2 Key Market Segments
1.2.1 Orally Administered Vaccine Segment by Type
1.2.2 Orally Administered Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ORALLY ADMINISTERED VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ORALLY ADMINISTERED VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Orally Administered Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orally Administered Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orally Administered Vaccine Sales Sites, Area Served, Product Type
3.6 Orally Administered Vaccine Market Competitive Situation and Trends
3.6.1 Orally Administered Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ORALLY ADMINISTERED VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Orally Administered Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ORALLY ADMINISTERED VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Orally Administered Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Orally Administered Vaccine Price by Type (2019-2024)
7 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orally Administered Vaccine Market Sales by Application (2019-2024)
7.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
8 ORALLY ADMINISTERED VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Orally Administered Vaccine Sales by Region
8.1.1 Global Orally Administered Vaccine Sales by Region
8.1.2 Global Orally Administered Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Orally Administered Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orally Administered Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orally Administered Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orally Administered Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orally Administered Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Merck
9.1.1 Merck Orally Administered Vaccine Basic Information
9.1.2 Merck Orally Administered Vaccine Product Overview
9.1.3 Merck Orally Administered Vaccine Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Orally Administered Vaccine SWOT Analysis
9.1.6 Merck Recent Developments
9.2 GSK
9.2.1 GSK Orally Administered Vaccine Basic Information
9.2.2 GSK Orally Administered Vaccine Product Overview
9.2.3 GSK Orally Administered Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Orally Administered Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Orally Administered Vaccine Basic Information
9.3.2 Sanofi Orally Administered Vaccine Product Overview
9.3.3 Sanofi Orally Administered Vaccine Product Market Performance
9.3.4 Sanofi Orally Administered Vaccine SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Institute
9.4.1 Lanzhou Institute Orally Administered Vaccine Basic Information
9.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
9.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
9.4.4 Lanzhou Institute Business Overview
9.4.5 Lanzhou Institute Recent Developments
9.5 Serum Institute
9.5.1 Serum Institute Orally Administered Vaccine Basic Information
9.5.2 Serum Institute Orally Administered Vaccine Product Overview
9.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
9.5.4 Serum Institute Business Overview
9.5.5 Serum Institute Recent Developments
9.6 Valneva
9.6.1 Valneva Orally Administered Vaccine Basic Information
9.6.2 Valneva Orally Administered Vaccine Product Overview
9.6.3 Valneva Orally Administered Vaccine Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Orally Administered Vaccine Basic Information
9.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
9.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Orally Administered Vaccine Basic Information
9.8.2 Bibcol Orally Administered Vaccine Product Overview
9.8.3 Bibcol Orally Administered Vaccine Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Orally Administered Vaccine Basic Information
9.9.2 PaxVax Orally Administered Vaccine Product Overview
9.9.3 PaxVax Orally Administered Vaccine Product Market Performance
9.9.4 PaxVax Business Overview
9.9.5 PaxVax Recent Developments
9.10 Vabiotech
9.10.1 Vabiotech Orally Administered Vaccine Basic Information
9.10.2 Vabiotech Orally Administered Vaccine Product Overview
9.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Orally Administered Vaccine Basic Information
9.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
9.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Orally Administered Vaccine Basic Information
9.12.2 EuBiologics Orally Administered Vaccine Product Overview
9.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
9.12.4 EuBiologics Business Overview
9.12.5 EuBiologics Recent Developments
9.13 Panacea Biotec Ltd
9.13.1 Panacea Biotec Ltd Orally Administered Vaccine Basic Information
9.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
9.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
9.13.4 Panacea Biotec Ltd Business Overview
9.13.5 Panacea Biotec Ltd Recent Developments
9.14 Bio-Med
9.14.1 Bio-Med Orally Administered Vaccine Basic Information
9.14.2 Bio-Med Orally Administered Vaccine Product Overview
9.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
9.14.4 Bio-Med Business Overview
9.14.5 Bio-Med Recent Developments
9.15 Halfkin Bio-Pharmaceuticals
9.15.1 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
9.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
9.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
9.15.4 Halfkin Bio-Pharmaceuticals Business Overview
9.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
10 ORALLY ADMINISTERED VACCINE MARKET FORECAST BY REGION
10.1 Global Orally Administered Vaccine Market Size Forecast
10.2 Global Orally Administered Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Orally Administered Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Orally Administered Vaccine Market Size Forecast by Region
10.2.4 South America Orally Administered Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Orally Administered Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Orally Administered Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Orally Administered Vaccine by Type (2025-2030)
11.1.2 Global Orally Administered Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Orally Administered Vaccine by Type (2025-2030)
11.2 Global Orally Administered Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Orally Administered Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Orally Administered Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Orally Administered Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Orally Administered Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Orally Administered Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Orally Administered Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Orally Administered Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Administered Vaccine as of 2022)
Table 10. Global Market Orally Administered Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Orally Administered Vaccine Sales Sites and Area Served
Table 12. Manufacturers Orally Administered Vaccine Product Type
Table 13. Global Orally Administered Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Orally Administered Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Orally Administered Vaccine Market Challenges
Table 22. Global Orally Administered Vaccine Sales by Type (Kilotons)
Table 23. Global Orally Administered Vaccine Market Size by Type (M USD)
Table 24. Global Orally Administered Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Orally Administered Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Orally Administered Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Orally Administered Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Orally Administered Vaccine Sales (Kilotons) by Application
Table 30. Global Orally Administered Vaccine Market Size by Application
Table 31. Global Orally Administered Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Orally Administered Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Orally Administered Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Orally Administered Vaccine Market Share by Application (2019-2024)
Table 35. Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Orally Administered Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Orally Administered Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Orally Administered Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Orally Administered Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Orally Administered Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Orally Administered Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Orally Administered Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Orally Administered Vaccine Basic Information
Table 44. Merck Orally Administered Vaccine Product Overview
Table 45. Merck Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Orally Administered Vaccine SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Orally Administered Vaccine Basic Information
Table 50. GSK Orally Administered Vaccine Product Overview
Table 51. GSK Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Orally Administered Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Orally Administered Vaccine Basic Information
Table 56. Sanofi Orally Administered Vaccine Product Overview
Table 57. Sanofi Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Orally Administered Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute Orally Administered Vaccine Basic Information
Table 62. Lanzhou Institute Orally Administered Vaccine Product Overview
Table 63. Lanzhou Institute Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute Business Overview
Table 65. Lanzhou Institute Recent Developments
Table 66. Serum Institute Orally Administered Vaccine Basic Information
Table 67. Serum Institute Orally Administered Vaccine Product Overview
Table 68. Serum Institute Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute Business Overview
Table 70. Serum Institute Recent Developments
Table 71. Valneva Orally Administered Vaccine Basic Information
Table 72. Valneva Orally Administered Vaccine Product Overview
Table 73. Valneva Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Valneva Business Overview
Table 75. Valneva Recent Developments
Table 76. Shanghai United Cell Orally Administered Vaccine Basic Information
Table 77. Shanghai United Cell Orally Administered Vaccine Product Overview
Table 78. Shanghai United Cell Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai United Cell Business Overview
Table 80. Shanghai United Cell Recent Developments
Table 81. Bibcol Orally Administered Vaccine Basic Information
Table 82. Bibcol Orally Administered Vaccine Product Overview
Table 83. Bibcol Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bibcol Business Overview
Table 85. Bibcol Recent Developments
Table 86. PaxVax Orally Administered Vaccine Basic Information
Table 87. PaxVax Orally Administered Vaccine Product Overview
Table 88. PaxVax Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. PaxVax Business Overview
Table 90. PaxVax Recent Developments
Table 91. Vabiotech Orally Administered Vaccine Basic Information
Table 92. Vabiotech Orally Administered Vaccine Product Overview
Table 93. Vabiotech Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vabiotech Business Overview
Table 95. Vabiotech Recent Developments
Table 96. Tiantan Biological Orally Administered Vaccine Basic Information
Table 97. Tiantan Biological Orally Administered Vaccine Product Overview
Table 98. Tiantan Biological Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Tiantan Biological Business Overview
Table 100. Tiantan Biological Recent Developments
Table 101. EuBiologics Orally Administered Vaccine Basic Information
Table 102. EuBiologics Orally Administered Vaccine Product Overview
Table 103. EuBiologics Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. EuBiologics Business Overview
Table 105. EuBiologics Recent Developments
Table 106. Panacea Biotec Ltd Orally Administered Vaccine Basic Information
Table 107. Panacea Biotec Ltd Orally Administered Vaccine Product Overview
Table 108. Panacea Biotec Ltd Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Panacea Biotec Ltd Business Overview
Table 110. Panacea Biotec Ltd Recent Developments
Table 111. Bio-Med Orally Administered Vaccine Basic Information
Table 112. Bio-Med Orally Administered Vaccine Product Overview
Table 113. Bio-Med Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bio-Med Business Overview
Table 115. Bio-Med Recent Developments
Table 116. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
Table 117. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
Table 118. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Halfkin Bio-Pharmaceuticals Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Recent Developments
Table 121. Global Orally Administered Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Orally Administered Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Orally Administered Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Orally Administered Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Orally Administered Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Orally Administered Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Orally Administered Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Orally Administered Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Orally Administered Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Orally Administered Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Orally Administered Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Orally Administered Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Orally Administered Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Orally Administered Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Orally Administered Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Orally Administered Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Orally Administered Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Orally Administered Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Administered Vaccine as of 2022)
Table 10. Global Market Orally Administered Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Orally Administered Vaccine Sales Sites and Area Served
Table 12. Manufacturers Orally Administered Vaccine Product Type
Table 13. Global Orally Administered Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Orally Administered Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Orally Administered Vaccine Market Challenges
Table 22. Global Orally Administered Vaccine Sales by Type (Kilotons)
Table 23. Global Orally Administered Vaccine Market Size by Type (M USD)
Table 24. Global Orally Administered Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Orally Administered Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Orally Administered Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Orally Administered Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Orally Administered Vaccine Sales (Kilotons) by Application
Table 30. Global Orally Administered Vaccine Market Size by Application
Table 31. Global Orally Administered Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Orally Administered Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Orally Administered Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Orally Administered Vaccine Market Share by Application (2019-2024)
Table 35. Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Orally Administered Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Orally Administered Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Orally Administered Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Orally Administered Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Orally Administered Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Orally Administered Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Orally Administered Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Merck Orally Administered Vaccine Basic Information
Table 44. Merck Orally Administered Vaccine Product Overview
Table 45. Merck Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Merck Business Overview
Table 47. Merck Orally Administered Vaccine SWOT Analysis
Table 48. Merck Recent Developments
Table 49. GSK Orally Administered Vaccine Basic Information
Table 50. GSK Orally Administered Vaccine Product Overview
Table 51. GSK Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Orally Administered Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Orally Administered Vaccine Basic Information
Table 56. Sanofi Orally Administered Vaccine Product Overview
Table 57. Sanofi Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Orally Administered Vaccine SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Lanzhou Institute Orally Administered Vaccine Basic Information
Table 62. Lanzhou Institute Orally Administered Vaccine Product Overview
Table 63. Lanzhou Institute Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Lanzhou Institute Business Overview
Table 65. Lanzhou Institute Recent Developments
Table 66. Serum Institute Orally Administered Vaccine Basic Information
Table 67. Serum Institute Orally Administered Vaccine Product Overview
Table 68. Serum Institute Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Serum Institute Business Overview
Table 70. Serum Institute Recent Developments
Table 71. Valneva Orally Administered Vaccine Basic Information
Table 72. Valneva Orally Administered Vaccine Product Overview
Table 73. Valneva Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Valneva Business Overview
Table 75. Valneva Recent Developments
Table 76. Shanghai United Cell Orally Administered Vaccine Basic Information
Table 77. Shanghai United Cell Orally Administered Vaccine Product Overview
Table 78. Shanghai United Cell Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Shanghai United Cell Business Overview
Table 80. Shanghai United Cell Recent Developments
Table 81. Bibcol Orally Administered Vaccine Basic Information
Table 82. Bibcol Orally Administered Vaccine Product Overview
Table 83. Bibcol Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bibcol Business Overview
Table 85. Bibcol Recent Developments
Table 86. PaxVax Orally Administered Vaccine Basic Information
Table 87. PaxVax Orally Administered Vaccine Product Overview
Table 88. PaxVax Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. PaxVax Business Overview
Table 90. PaxVax Recent Developments
Table 91. Vabiotech Orally Administered Vaccine Basic Information
Table 92. Vabiotech Orally Administered Vaccine Product Overview
Table 93. Vabiotech Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Vabiotech Business Overview
Table 95. Vabiotech Recent Developments
Table 96. Tiantan Biological Orally Administered Vaccine Basic Information
Table 97. Tiantan Biological Orally Administered Vaccine Product Overview
Table 98. Tiantan Biological Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Tiantan Biological Business Overview
Table 100. Tiantan Biological Recent Developments
Table 101. EuBiologics Orally Administered Vaccine Basic Information
Table 102. EuBiologics Orally Administered Vaccine Product Overview
Table 103. EuBiologics Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. EuBiologics Business Overview
Table 105. EuBiologics Recent Developments
Table 106. Panacea Biotec Ltd Orally Administered Vaccine Basic Information
Table 107. Panacea Biotec Ltd Orally Administered Vaccine Product Overview
Table 108. Panacea Biotec Ltd Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Panacea Biotec Ltd Business Overview
Table 110. Panacea Biotec Ltd Recent Developments
Table 111. Bio-Med Orally Administered Vaccine Basic Information
Table 112. Bio-Med Orally Administered Vaccine Product Overview
Table 113. Bio-Med Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Bio-Med Business Overview
Table 115. Bio-Med Recent Developments
Table 116. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
Table 117. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
Table 118. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Halfkin Bio-Pharmaceuticals Business Overview
Table 120. Halfkin Bio-Pharmaceuticals Recent Developments
Table 121. Global Orally Administered Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Orally Administered Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Orally Administered Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Orally Administered Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Orally Administered Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Orally Administered Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Orally Administered Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Orally Administered Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Orally Administered Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Orally Administered Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Orally Administered Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Orally Administered Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Orally Administered Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Orally Administered Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Orally Administered Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Orally Administered Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Orally Administered Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Orally Administered Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Orally Administered Vaccine Market Size by Country (M USD)
Figure 11. Orally Administered Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Orally Administered Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Orally Administered Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Orally Administered Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Orally Administered Vaccine Market Share by Type
Figure 18. Sales Market Share of Orally Administered Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Orally Administered Vaccine by Type in 2023
Figure 20. Market Size Share of Orally Administered Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Orally Administered Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Orally Administered Vaccine Market Share by Application
Figure 24. Global Orally Administered Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Orally Administered Vaccine Sales Market Share by Application in 2023
Figure 26. Global Orally Administered Vaccine Market Share by Application (2019-2024)
Figure 27. Global Orally Administered Vaccine Market Share by Application in 2023
Figure 28. Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Orally Administered Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Orally Administered Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Orally Administered Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Orally Administered Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Orally Administered Vaccine Sales Market Share by Region in 2023
Figure 44. China Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Orally Administered Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Orally Administered Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Orally Administered Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Orally Administered Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Orally Administered Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Orally Administered Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Orally Administered Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Orally Administered Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Orally Administered Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Orally Administered Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Orally Administered Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Orally Administered Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Orally Administered Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Orally Administered Vaccine Market Size by Country (M USD)
Figure 11. Orally Administered Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Orally Administered Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Orally Administered Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Orally Administered Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Orally Administered Vaccine Market Share by Type
Figure 18. Sales Market Share of Orally Administered Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Orally Administered Vaccine by Type in 2023
Figure 20. Market Size Share of Orally Administered Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Orally Administered Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Orally Administered Vaccine Market Share by Application
Figure 24. Global Orally Administered Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Orally Administered Vaccine Sales Market Share by Application in 2023
Figure 26. Global Orally Administered Vaccine Market Share by Application (2019-2024)
Figure 27. Global Orally Administered Vaccine Market Share by Application in 2023
Figure 28. Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Orally Administered Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Orally Administered Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Orally Administered Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Orally Administered Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Orally Administered Vaccine Sales Market Share by Region in 2023
Figure 44. China Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Orally Administered Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Orally Administered Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Orally Administered Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Orally Administered Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Orally Administered Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Orally Administered Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Orally Administered Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Orally Administered Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Orally Administered Vaccine Market Share Forecast by Application (2025-2030)
